The heart-protective effects provide defense against cardiovascular disease through reduced inflammation and improved cholesterol profiles
GLP-1 receptor agonists are FDA-approved for two primary indications: type 2 diabetes (Ozempic, Mounjaro, Victoza, Trulicity, Rybelsus) to improve glycemic control, and chronic weight management (Wegovy, Zepbound) for adults with a BMI of 30+ or BMI 27+ with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
The heart compensates for this loss of power by enlarging, developing more muscle, pumping faster, narrowing blood vessels, and diverting blood to vital organs
"As obesity rates continue to rise, there's a growing demand for effective weight-loss solutions," says GP and Integrative Wellbeing Coach, Dr Rosie Khan
How GLP-1 Is Made (Proglucagon Pathway) The production of GLP-1 begins with a larger precursor molecule
Quesada-Gonzlez, D